Atlas Trials

Compare the Outcomes of XT and XEC Adjuvant Chemotherapy in HER2-negative Luminal B Breast Cancer Patients

Clinical trial NCT01779531 · UNKNOWN

Trial details

NCT number
NCT01779531
Sponsor
Guangdong Academy of Medical Sciences
Status
UNKNOWN
Study type
OBSERVATIONAL
Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
Start date
2013-01-01
Primary completion
2014-06-01
Enrollment
640

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.